Nanobodies: new avenue to treat kidney disease

Cell Tissue Res. 2021 Aug;385(2):445-456. doi: 10.1007/s00441-021-03479-8. Epub 2021 Jun 16.

Abstract

Current therapeutic options for renal diseases are limited, and the search for disease-specific treatments is ongoing. Nanobodies, single-domain antibodies with many advantages over conventional antibodies, provide flexible, easy-to-format biologicals with many possible applications. Here, we discuss the potential use of nanobodies for renal diseases.

Keywords: Conventional antibodies; Nanobodies; Renal diseases.

Publication types

  • Review

MeSH terms

  • Animals
  • Humans
  • Kidney Diseases / therapy*
  • Single-Domain Antibodies / therapeutic use*

Substances

  • Single-Domain Antibodies